Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Am J Ophthalmol. 2020 Apr 10;216:132–139. doi: 10.1016/j.ajo.2020.04.006

Corneal Epithelial Thickness Measured Using AS-OCT as a Diagnostic Parameter for Limbal Stem Cell Deficiency

Qingfeng Liang 1,2, Qihua Le 1, Daniel W Cordova 1, Chi-Hong Tseng 3, Sophie X Deng 1,*
PMCID: PMC7434708  NIHMSID: NIHMS1584111  PMID: 32283095

Abstract

Objective:

Using anterior segment optical coherence tomography (AS-OCT), we investigated the epithelial thickness (ET) of the central cornea and limbal regions in patients with limbal stem cell deficiency (LSCD) as a diagnostic and staging parameter.

Design:

Prospective, cross-sectional study

Methods:

The central corneal epithelium thickness (CET) and maximum limbal epithelium thickness (mLET) were measured in the superior, inferior, nasal, and temporal limbus on AS-OCT images of the normal and eyes with LSCD. CET was obtained by 1-point (OCT-CET1) and 3-point measurement (OCT-CET3). The values of OCT-CET1 and OCT-CET3 were compared to the CET obtained with in vivo confocal microscopy (IVCM-CET).

Results:

Sixty-eight eyes of 50 patients with LSCD and 52 eyes of 34 normal subjects were included. The mean (±SD) OCT-CET3 was 55.0±3.0 μm (range, 50.6–62.0 μm) in the control group and 41.6±10.8 μm (range, 0–56.3 μm) in the LSCD group (P<0.001). OCT-CET3 had a better correlation with IVCM-CET (r=0.91) than did OCT-CET1 (r=0.87, P=0.001). The degree of reduction in OCT-CET3 increased in more advanced clinical stages of LSCD (all P<0.001). The OCT-CET3 cutoff value that suggests LSCD was 46.6 μm. Compared with the control group, the LSCD group had decreases in mLET in all four limbal regions (all P <0.001). The sensitivity and specificity of OCT-CET3 is the highest among all mLET in detecting LSCD.

Conclusions:

Both CET and mLET were thinner in patients with LSCD than in normal subjects. OCT-CET3 appears to be a reliable parameter to confirm LSCD when there is clinical suspicion.

Keywords: limbal stem cell deficiency, limbal stem cells, anterior segment optical coherence tomography, epithelium thickness, diagnosis

Introduction

Corneal epithelial maintenance and regeneration depend on a sufficient amount of functional limbal stem cells (LSCs) located in the corneoscleral limbus.1 The reduction in the population of LSCs and their dysfunction results in abnormal corneal epithelialization and invasion of the corneal surface by the conjunctival epithelium with or without corneal neovascularization, i.e., limbal stem cell deficiency (LSCD).2 Becauseof the limitation of clinical signs in the diagnosis of LSCD in the past,3, 4 the global consensus on the diagnosis of LSCD suggests additional laboratory tests, such as impression cytology to detect goblet cells, the use of conjunctival markers to identify conjunctival epithelial cells,2, 57and/or in vivo imaging to confirm the diagnosis of LSCD.813

The epithelial thickness (ET) of the cornea and limbus is a potentially important parameter for use in evaluating and monitoring the function of LSCs.11 The repair and renewal of the corneal epithelium are related to the amount of functional LSCs. In patients with severe LSCD, persistent epithelial defects, epithelial thinning, irregularity, and opacity are often present. Findings from others and from our group show that epithelial thinning is observed in eyes with LSCD.9, 11, 13, 14 An association of the degree of epithelial thinning with the severity of LSCD was found by in vivo confocal microscopy (IVCM).11Anterior segment optical coherence tomography (AS-OCT) is more readily available and easier to perform than IVCM. Therefore, AS-OCT potentially is a better approach to measure ET and may be effective as an initial diagnostic tool to confirm LSCD when there is clinical suspicion. Using AS-OCT, Banayan et al.13 found that the difference between the minimal and the maximal ET and the variation of ET were significantly higher in those with LSCD than in those without LSCD. However, a precise grading and detection of the LSCD severity are still lacking. Recently, a more precise clinical staging system was established by the International LSCD Working group.2 In the current study, we investigated different methods to determine ET by using AS-OCT and IVCM, and we correlated the degree of epithelial thinning in the central cornea and limbus in eyes with different clinical stages of LSCD to establish a cutoff value of ET that signifies LSC dysfunction.

Methods

Subjects

This prospective, cross-sectional, comparative, single-center study was conducted at the Stein Eye Institute with the approval of the Institutional Review Board at the University of California, Los Angeles (UCLA Institutional Review Board #10–001601). All subjects were informed of the aims of the study, and the study was adherent to the Declaration of Helsinki. Appropriate consent was obtained prior to the study.

Patients with LSCD were consecutively recruited from 2009 to 2018, and the diagnosis of LSCD was first based on results from clinical presentation and then confirmed by IVCM (HRT III, Heidelberg Engineering GmBH, Dossenheim, Germany) and/or impression cytology according to the criteria set by the International LSCD Working Group.2 All subjects underwent AS-OCT, and all patients with LSCD and 17 control subjects underwent IVCM. Impression cytology was performed for 13 patients who consented to this test. The control group consisted of subjects without a history of eye disease and free of any ocular surface abnormality that could have been detected by slit-lamp examination. The control subjects with a contact lens–wearing history (continuous use over 2 weeks) and/or a history of any ocular surface surgery were excluded.

Using a previously established clinical scoring system based on the extent of limbus and corneal surface involvement (range of total score: 2–10 points),15 we classified the stages of LSCD as mild (range, 2–4 points), moderate (range, 5–7 points), and severe (range, 8–10 points). The mild, moderate, and severe stages correlate with the stages I, II, and III (established by the International LSCD Working Group), respectively.

Anterior Segment Optical Coherence Tomography

A Fourier-domain OCT system (RTVue-100; Optovue, Inc., Fremont, CA) with a wide-angle (long) corneal anterior module lens was used. The central corneal epithelium thickness (CET) and maximum limbal epithelium thickness (mLET) were measured. The cross-line scan mode was used to obtain the images of the central cornea and the single-line scan mode was used to obtain images of each limbus quadrant (superior, inferior, nasal, and temporal) with the scleral spur visible. The images of limbus without a clear scleral spur or iris root structure were taken again or excluded from the analysis. A minimum of 3 scans was acquired at each location.

CET was defined as the straight distance between the tear film (first hyperreflective layer) and the basement membrane (second hyperreflective layer).The value of CET was measured with 2 manual methods: 1-point measurement (OCT-CET1) at the center of the cornea and 3-point measurement (OCT-CET3, Figure 1 upper) at 1 mm outside the center of the cornea. In cases of severe LSCD with subepithelial fibrosis at presentation, the epithelial layer could not be detected in AS-OCT images, and the CET measurement of 0 μm was given. Eyes with epithelial defect was excluded from the study.

Figure 1.

Figure 1.

Measurement of corneal epithelial thickness (CET, upper) and maximal limbal epithelial thickness (mLET, lower) by using anterior segment optical coherence tomography (OCT). The center of the cornea and 2 points at 1 mm away from the center of the cornea were located (Upper left). CET was measured at these 3 locations from a point beneath the tear film (first hyperreflective layer) to the basal membrane (second hyperreflective layer). The value of CET in the center of the cornea was OCT-CET1, and the mean of these 3 points was OCT-CET3. “Line a” is perpendicular to the tangent of the limbal surface, which crosses the scleral spur (SS); “line b” is a connecting line between the ending points of Bowman’s layer and Descemet’s membrane. The limbal epithelium area (LEA) is defined by 2 white solid lines (“line a” and “line b”). The thickest part of the LEA was located, and the mLET was measured.

The mLET was measured manually. First, the limbal epithelium area (LEA) was defined as the area between the lines crossing the scleral spur and the end of Bowman’s layer. Second, the thickest part with the LEA was measured, and this measurement was recorded as the mLET (Figure bottom). Lastly, the mLET was determined in 3 independent OCT scans at each limbal quadrant, and the mean value of these 3 results was considered to be the mLET in this limbal quadrant. All measurements were performed by 2 independent, masked observers.

In Vivo Confocal Microscopy

CET was determined with the image recognition method from “volume” scan mode of in vivo confocal microscopy.10 Series confocal images of the central cornea were taken by using the “volume” scan mode on an HRT III. A minimum of 3 high-quality Z scans were acquired. Only those scans with the least amount of motion artifacts underwent analysis. Two independent, masked observers then measured the CET, which was defined as the scan depth difference between the most superficial layer of epithelium and the basal layer. The mean value of 3 measurements served as the IVCM-CET.

Statistical Analysis

Statistical analysis was performed with R software (www.r-project.org). CET and mLET values (mean ± SD) were summarized and compared among the control group and the group of patients with LSCD at different stages by using ANOVA (analysis of variance) methods. The relationship of CET detected by using AS-OCT and IVCMwas characterized by scatter plots and Pearson correlation coefficients with all subjects. All of the above measurements (OCT-CET1, OCT-CET3, IVCM-CET, and mLET) were performed by 2 independent, masked observers. Interobserver differences were calculated to assess the interoperator variation between 2 independent observers. The receiver operating characteristic (ROC) curves (AUC) were generated to examine the sensitivity and specificity of CET and mLET values to detect LSCD. All tests were 2-sided, and any P value ≤ 0.05 indicated statistical significance.

Results

Patient Characteristics

A total of 120 eyes were included: 68 eyes of 50 patients with LSCD and 52 eyes of 34 normal control subjects. The mean age (±SD) was 67.3±17.6 years (range, 19–90 years) in the LSCD group and 50.4±18.2 years (range, 19–89 years) in the control group (P<0.001). There was no significant difference in gender between the control and LSCD groups (P=0.9). All subjects were Caucasian. The leading etiologies of LSCD were multiple ocular surgeries (34 eyes; 50.0%), contact lens wear (11 eyes, 16.2%), drug toxicity (7 eyes, 10.3%), and mucous membrane pemphigoid (6 eyes, 8.8%).

The mild stage (stage I) of LSCD was observed in 27 eyes (39.7%); the moderate stage (stage II), in 27 eyes (39.7%); and the severe stage (stage III), in 14 eyes (20.6%). The mean (±SD) visual acuity in logMAR was 0.0±0.0 in the control group and 1.1±0.7 in the LSCD group (P<0.001). As the severity of the LSCD increased, the visual acuity decreased (Table). The clinical manifestations included stippling fluorescein staining in a vortex pattern of the cornea, minimal peripheral superficial neovascularization, and, in some patients, a persistent epithelial defect. The slit-lamp images of different stages are shown in Figure 2. The average clinical score (±SD)was 2.4±1.1 points (range, 1–4 points) in stage I LSCD, 6.3±1.1 points (range, 5–7 points) in stage II LSCD, and 9.0±1.0 points (range, 8–10 points) in stage III LSCD. For the 13 patients who consented to impression cytology, goblet cells were detected on the cytology samples in all cases.

TABLE.

Clinical Characteristics of Patients with Limbal Stem Cell Deficiency and Normal Controls

Control group LSCD group P* Subgroup comparison P<0.05
All Stage I Stage II Stage III
Eyes (%) 52 69 27(39.7) 27(39.7) 14(20.6)
BCVA logMAR 0.0±0.0 1.1±0.7 0.6±0.9 1.4±1.3 1.6±1.0 <0.001 1, 2, 3, 4, 5
Clinical Score 0±0 5.35±2.76 2.4±1.1 6.3±1.1 9.0±1.0 <0.001 1, 2, 3, 4, 5, 6
OCT-CET3 (μm) 55.0±3.0 41.6±10.8 49.5±2.9 38.9±9.6 32.8±12.2 <0.001 1,2, 3, 4, 5, 6
mLET (μm)
 Superior 108.4±23.8 68.0±21.7 72.8±19.9 64.3±24.3 65.8±19.5 <0.001 1, 2, 3
 Inferior 102.0±27.0 71.8±21.4 71.3±16.5 75.3±26.3 66.0±19.0 <0.001 1, 2, 3
 Nasal 86.7±14.6 69.0±17.5 72.9±19.3 70.6±16.5 58.4±11.4 <0.001 1, 2, 3, 5, 6
 Temporal 84.6±14.1 70.3±17.4 78.0±15.9 66.3±16.7 63.1±16.9 <0.001 2, 3, 4, 5
*

P values of ANOVA performed among the control group and LSCD groups; In subgroup comparison, 1. Control vs. Stage I; 2. Control vs. Stage II; 3. Control vs. Stage III; 4. Stage I vs. Stage II; 5. Stage I vs. Stage III; 6. Stage II vs. Stage III.

Figure 2.

Figure 2.

Representative examples of corneal epithelial thickness and maximal limbal epithelial thickness (mLET) using anterior segment optical coherence tomography (AS-OCT) in the control subjects and patients with limbal stem cell deficiency (LSCD) in different stages of severity. Slit-lamp photos (left), fluorescein staining patterns (middle left), AS-OCT images of the central (middle right), and mLET (right) in the control subjects and patients with LSCD are shown. The epithelium in the normal eye is transparent and devoid of fluorescein staining (top left). In LSCD, affected area exhibited stippled fluorescein staining in a whorl-like pattern or pooling (bottom left 3 panels). There was epithelial thinning as outlined by the fluorescein staining in the cornea and affected limbal regions (left middle bottom 3 panels).

Central Corneal Epithelium Thickness

The method of measuring CET is described in Figure 1. Measurements were highly consistent (<5% variation) between the 2 independent observers (Supplement Table 1). The mean (±SD) OCT-CET1 was 54.0±3.5 μm in normal controls and 41.4±10.9 μm in the LSCD group. The mean (±SD) OCT-CET3 was 55.0±3.0 μm in normal controls and 41.6±10.8 μm in the LSCD group. There were no significant differences between the 2 measurements (P>0.05). However, the OCT-CET3 had a better correlation with the IVCM-CET (r=0.91) than did the OCT-CET1 (r=0.87, Supplement Figure 1). Therefore, OCT-CET3 was used to evaluate CET in the rest of the study.

Most patients (36 cases, 72.0%) were older than 60 years in the LSCD group, whereas 13 subjects (38.2%) in the control group were older than 60 years. To control for the age variation, the subjects were categorized as <60 years of age and ≥60 years of age. There was no difference in the mean (±SD) OCT-CET3 values between the older age subgroup (54.9±2.7 μm) and the younger age subgroup (55.8±2.8 μm) of normal subjects (P=0.278). The mean OCT-CET3 was also found to be similar between the younger and older subgroups of patients with LSCD in any of the 3 stages (all P>0.05, Supplement Figure 2). Therefore, the age effect on CET is negligible. The remaining analyses were performed on the entire LSCD group and control group.

The epithelial layer in eyes with LSCD exhibited greater reflectivity than did the same layer, which was hyporeflective, in normal eyes. Reflectivity in the anterior stroma of eyes with LSCD was also greater than that in the eyes of control subjects (Figure 2). Compared to the mean OCT-CET3 of the control group (55.0±3.0 μm), the mean OCT-CET3 of the LSCD group was significantly less (41.6±10.8 μm, P<0.001). The OCT-CET3 decreased with increasing severity of the disease (Figure 3). The OCT-CET3 was reduced by 10.3% in the group with stage I LSCD (49.5±2.9 μm), by 29.6% in the group with stage II LSCD (38.9±9.6 μm), and by 42.9% in the group with stage III LSCD (31.4±11.8 μm, P<0.001, Table). The cutoff value for OCT-CET3 that distinguished LSCD from a normal limbus was 46.6 μm; the sensitivity was 61.7% and the specificity was 100%. The AUC of the OCT-CET3 cutoff value was 0.973.

Figure 3.

Figure 3.

The box and whisker plots of the central corneal epithelial thickness obtained by 3-point measurement (OCT-CET3) in the control subjects and in patients with limbal stem cell deficiency (LSCD). The right figure is the receiver operation curve (ROC) of OCT-CET3 for detecting LSCD; the method provides (AUC=0.973) 58.8% sensitivity and 100% specificity in detecting LSCD.

The OCT-CET3 in the affected (34.8±11.3 μm) and unaffected (48.3±3.8 μm) visual axis area differed significantly (P<0.001). In patients with LSCD without visual axis involvement, the OCT-CET3 (48.3±3.8 μm) was less than that of the control group (55.2±2.8 μm; P<0.001). Furthermore, the degree of OCT-CET3 reduction increased with the extent of the ocular surface involvement. The OCT-CET3 was 47.9±5.6 μm for patients with 1 quadrant of the corneal surface affected, 41.5±7.4 μm with 2 quadrants of the corneal surface affected, 37.2±11.3 μm with 3 quadrants of the corneal surface affected, and 36.5±10.5 μm with all 4 quadrants of the corneal surface affected (P<0.001).

Limbal Epithelium Thickness

There was no difference in the mLET of the superior, inferior, nasal, and temporal quadrant between the older and younger subgroups of normal subjects (P>0.05, Supplement Table 2). This finding suggested that age did not influence the mLET significantly. Therefore, the mLET values of the entire cohort were used in the rest of the analyses.

Compared with the mLET in the control group, the mLET in the LSCD group was significantly less in all 4 limbal quadrants (all P <0.001, Table). The superior limbus was the most commonly affected area (51 eyes, 75.0%), followed by the inferior area (36 eyes, 52.9%), nasal area (32 eyes, 47.1%), and temporal area (27 eyes, 39.7%).

The degree of mLET reduction varied among the 4 quadrants of limbus (Table); the greatest reduction was observed in the superior and inferior limbus. In patients with LSCD, the mLET in the clinically affected region was significantly less than that in the corresponding region of control subjects (Figure 4, all P<0.01). Meanwhile, the unaffected regions also had a significantly thinner mLET than the corresponding limbal regions in the controls (all P<0.01). However, there was no significant difference in mLET between the affected and unaffected limbal regions in LSCD group (all P >0.05, Supplement Table 3). Receiver operating characteristic (ROC) curve analysis of the mLET in the control subjects and patients with LSCD revealed that the AUC of mLET cutoff value was 0.898 in the superior limbus, 0.827 in the inferior region, 0.790 in the nasal region, and 0.730 in the temporal region (Supplement Figure 3). The AUC in all limbal regions were lower than that of OCT-CET3.

Figure 4.

Figure 4.

Box and whisker plots of maximal limbal epithelial thickness in the control subjects and in the patients with LSCD at different stages.

Discussion

Consistent with previous findings based on IVCM results, the ET of the cornea and limbus measured by AS-OCT decreased with the increasing severity of LSCD in the LSCD group. Our results suggest that the OCT-CET3 had the highest diagnostic value for LSCD and the mLET in the superior and the inferior limbal region had the second highest diagnostic value.

Previous studies revealed that CET and LET varies among patients of different ethnic backgrounds16 and age.17 In our study, only Caucasian subjects were included in the control group. We also analyzed the variance of OCT-CET3 and mLET in different age groups, but the difference between the older and younger subjects of the control group was not significant. Yang et al17 measured CET and LET in 180 healthy eyes (age range, 7–83 years) and found that the CET of the central 2-mm diameter zone had no significant change with aging. The difference among mean mLETs in different age groups was very small (about 3 μm), which is less than the 5-μm axis resolution of the AS-OCT system. The CET cutoff value between the patients with suspected LSCD and normal control subjects was similar in the older and younger subgroups. Therefore, age was not a confounding factor in the analysis of ET in LSCD measured by AS-OCT.

Although a characteristic of some corneal diseases such as keratoconus, post refractive surgery, and dry eye could present with a thinner ET, the epithelial remodeling is the primary mechanism of those diseases and the degree of epithelium thinning becomes limited in these diseases. For example, the CET reduction in patients with keratoconus is reported to be 9.2% of that of normal controls.18 The reduction of ET in dry eye is 1.6%.19 In LSCD, the average CET reduction was more than 20%, as epithelial renewal was negatively influenced by the insufficient number of functional LSCs. Mehtani et al. reported the CET reduction in LSCD cases was 32.6%, and Chan et al. reported a 20.2% reduction in patients with LSCD.11, 20 In addition, the epithelial layer in ocular surface squamous neoplasia is detected as hyperreflective above the Bowman’s layer using OCT.21 However, this is often accompanied by thickening of the ET in. Superficial keratectomy is necessary to obtain a diagnosis by histologic study in case of uncertainty of the underlying pathology.

In the present study, the OCT-CET3 cutoff suggests that LSCD was 46.6 μm, which is similar to the 45.5-μm cutoff obtained with IVCM. The OCT-CET reduction may be related to the decrease of basal cell density (BCD) and subbasal nerve density (SND) in the central cornea, which affect epithelial cell growth, proliferation, and regeneration. Chan et al. reported that BCD reduction was detected in mild sectoral LSCD; BCD in the central cornea decreased by 31.0% and by 23.6% in the limbus.10

Thus, the central cornea was identified as an area representative of the global function of LSCs. Although the visual axis of the cornea appeared to be unaffected as seen by clinical examination in some patients with stage I LSCD, the OCT-CET was less than that of the normal controls. This result indicates that the central cornea homeostasis is already affected. CET could serve as a parameter to evaluate the LSC function, especially in the early stages of the disease. Moreover, OCT-CET decreases as the number of affected limbal and corneal regions increases.

It is important to note that subepithelial fibrosis, which is detected as a hyperreflective layer, was often present in eyes with chronic moderate or severe LSCD. The hyper-reflectivity could interfere with the identification of the precise location of theepithelial layer and Bowman’s layer. Banayan and associates reported that limbal subepithelial fibrosis was detected in 76% of the eyes with LSCD and in none of the normal eyes.13 The absence of the palisades of Vogt and limbal crypts is often observed in older individuals and is not necessarily an indication of LSCD.22 In sectoral LSCD, a clear transition of the corneal epithelial layer (hyporeflective layer) to a thin hyperreflective layer is often observed (Fig 2, third image of the third row). Therefore, CET appears to be a more specific parameter than the absence of the palisades of Vogt in identifying LSCD.

There are limitations of our study. As mentioned above regarding the hyperreflective subepithelial fibrosis in severe LSCD, the accurate measurement of the CET and LET might be difficult. IVCM would be necessary as the next imaging test to further evaluate the phenotype and thickness of the epithelium in such cases. The current study has validated the use of AS-OCT in the measurement of ET in LSCD. CET reflects the global LSC function and could serve as the initial diagnostic test when there is clinical suspicion of LSCD. However, further studies are necessary to further determine the role as a specific parameter in the diagnosis of LSCD

In summary, the current study has validated the use of AS-OCT in the measurement of ET in LSCD. CET reflects the global LSC function and could serve as the initial diagnostic test when there is clinical suspicion of LSCD. Further confirmation and staging of LSCD could be achieved with IVCM.

Supplementary Material

1
2
3
4
5
6
7
8
9

Acknowledgments

  1. Funding/Support: This work is supported in part by an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology at the University of California, Los Angeles. SXD received grant support from the National Eye Institute (2R01 EY021797 and R01 EY028557), California Institute for Regenerative Medicine (TR2 TR2–01768, CLIN1–08686, CLIN2–11650).

  2. Financial Disclosures: SXD is a consultant for W. L. Gore & Associates, F-Prime Capital Partners, Dompe US and Kowa Research Institute, Inc. QL: None; DWC: None; CHT: None.

  3. Other acknowledgement: Statistical analysis was performed by Chi-hong Tseng, PhD. Editorial support was provided by Julia C. Jones, PharmD, PhD, MWC®, ELS.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Tseng SC. Concept and application of limbal stem cells. Eye (Lond) 1989;3 (Pt 2):141–57. [DOI] [PubMed] [Google Scholar]
  • 2.Deng SX, Borderie V, Chan CC, et al. Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency. Cornea 2019;38 (3):364–375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Le Q, Samson CM, Deng SX. A Case of Corneal Neovascularization Misdiagnosed as Total Limbal Stem Cell Deficiency. Cornea 2018;37 (8):1067–1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chan E, Le Q, Codriansky A, et al. Existence of Normal Limbal Epithelium in Eyes With Clinical Signs of Total Limbal Stem Cell Deficiency. Cornea 2016;35 (11):1483–1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jirsova K, Dudakova L, Kalasova S, Vesela V, Merjava S. The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency. Invest Ophthalmol Vis Sci 2011;52 (8):5892–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Poli M, Janin H, Justin V, et al. Keratin 13 immunostaining in corneal impression cytology for the diagnosis of limbal stem cell deficiency. Invest Ophthalmol Vis Sci 2011;52 (13):9411–5. [DOI] [PubMed] [Google Scholar]
  • 7.Ramirez-Miranda A, Nakatsu MN, Zarei-Ghanavati S, Nguyen CV, Deng SX. Keratin 13 is a more specific marker of conjunctival epithelium than keratin 19. Mol Vis 2011;17:1652–61. [PMC free article] [PubMed] [Google Scholar]
  • 8.Nubile M, Lanzini M, Miri A, et al. In vivo confocal microscopy in diagnosis of limbal stem cell deficiency. Am J Ophthalmol 2013;155 (2):220–32. [DOI] [PubMed] [Google Scholar]
  • 9.Deng SX, Sejpal KD, Tang Q, et al. Characterization of limbal stem cell deficiency by in vivo laser scanning confocal microscopy: a microstructural approach. Arch Ophthalmol 2012;130 (4):440–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chan EH, Chen L, Rao JY, Yu F, Deng SX. Limbal Basal Cell Density Decreases in Limbal Stem Cell Deficiency. Am J Ophthalmol 2015;160 (4):678–684 e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chan EH, Chen L, Yu F, Deng SX. Epithelial Thinning in Limbal Stem Cell Deficiency. Am J Ophthalmol 2015;160 (4):669–677 e4. [DOI] [PubMed] [Google Scholar]
  • 12.Chuephanich P, Supiyaphun C, Aravena C, et al. Characterization of the Corneal Subbasal Nerve Plexus in Limbal Stem Cell Deficiency. Cornea 2017;36 (3):347–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Banayan N, Georgeon C, Grieve K, Borderie VM. Spectral Domain Optical Coherence Tomography in Limbal Stem Cell Deficiency. A Case Control Study. Am J Ophthalmol 2018. [DOI] [PubMed] [Google Scholar]
  • 14.Hong J, Qian T, Yang Y, et al. Corneal epithelial thickness map in long-term soft contact lenses wearers. Optom Vis Sci 2014;91 (12):1455–61. [DOI] [PubMed] [Google Scholar]
  • 15.Aravena C, Bozkurt K, Chuephanich P, et al. Classification of Limbal Stem Cell Deficiency Using Clinical and Confocal Grading. Cornea 2019;38 (1):1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Le Q, Cordova D, Xu J, Deng SX. In Vivo Evaluation of the Limbus Using Anterior Segment Optical Coherence Tomography. Transl Vis Sci Technol 2018;7 (4):12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yang Y, Hong J, Deng SX, Xu J. Age-related changes in human corneal epithelial thickness measured with anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci 2014;55 (8):5032–8. [DOI] [PubMed] [Google Scholar]
  • 18.Pircher N, Schwarzhans F, Holzer S, et al. Distinguishing Keratoconic Eyes and Healthy Eyes Using Ultrahigh-Resolution Optical Coherence Tomography-Based Corneal Epithelium Thickness Mapping. Am J Ophthalmol 2018;189:47–54. [DOI] [PubMed] [Google Scholar]
  • 19.Cui X, Hong J, Wang F, et al. Assessment of corneal epithelial thickness in dry eye patients. Optom Vis Sci 2014;91 (12):1446–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mehtani A, Agarwal MC, Sharma S, Chaudhary S. Diagnosis of limbal stem cell deficiency based on corneal epithelial thickness measured on anterior segment optical coherence tomography. Indian J Ophthalmol 2017;65 (11):1120–1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Atallah M, Joag M, Galor A, et al. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases. Ocul Surf 2017;15 (4):688–695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zheng T, Xu J. Age-related changes of human limbus on in vivo confocal microscopy. Cornea 2008;27 (7):782–6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2
3
4
5
6
7
8
9

RESOURCES